Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)

This publication has 29 references indexed in Scilit:

• Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)
  Journal of Antimicrobial Chemotherapy, 2003
• Surveillance of antibiotic resistance in European ICUs
  Journal of Hospital Infection, 2001
• Surveillance of Antimicrobial Use and Antimicrobial Resistance in United States Hospitals: Project ICARE Phase 2
  Clinical Infectious Diseases, 1999
• Reduction in the Incidence of Methicillin‐Resistant Staphylococcus aureus and Ceftazidime‐Resistant Klebsiella pneumoniae Following Changes in a Hospital Antibiotic Formulary
  Clinical Infectious Diseases, 1999
• Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii
  Clinical Infectious Diseases, 1999
• Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance Program
  Clinical Infectious Diseases, 1996
• Predominant pathogens found in the European prevalence of infection in intensive care study
  European Journal of Clinical Microbiology & Infectious Diseases, 1996
• Treatment failure due to extended spectrum βlactamase
  Journal of Antimicrobial Chemotherapy, 1996
• Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis
  JAMA, 1995
• The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee
  JAMA, 1995